Perceptive Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-686,922
| Closed | -$90.4M | – | 173 |
|
|
2020
Q4 | $90.4M | Hold |
686,922
| – | – | 0.97% | 28 |
|
|
2020
Q3 | $34.7M | Hold |
686,922
| – | – | 0.51% | 52 |
|
|
2020
Q2 | $30.1M | Hold |
686,922
| – | – | 0.49% | 48 |
|
|
2020
Q1 | $33.7M | Sell |
686,922
-10,602
| -2% | -$519K | 0.88% | 26 |
|
|
2019
Q4 | $40M | Buy |
697,524
+10,532
| +2% | +$604K | 0.8% | 33 |
|
|
2019
Q3 | $24.7M | Hold |
686,992
| – | – | 0.67% | 35 |
|
|
2019
Q2 | $21.3M | Hold |
686,992
| – | – | 0.49% | 47 |
|
|
2019
Q1 | $16.1M | Buy |
686,992
+70
| +0% | +$1.64K | 0.45% | 44 |
|
|
2018
Q4 | $9.45M | Hold |
686,922
| – | – | 0.36% | 52 |
|
|
2018
Q3 | $6.86M | Hold |
686,922
| – | – | 0.18% | 65 |
|
|
2018
Q2 | $14M | Buy |
+686,922
| New | +$14M | 0.37% | 52 |
|